German Tech Holding eyes 10% stake in Zirnostics GmbH

German Tech Holding is evaluating a 10% minority stake in biotech startup Zirnostics, which focuses on cancer diagnostics radiopharmaceuticals and uses a clinically proven zirconium-89 PSMA PET/CT tracer.